- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
Boston Scientific Corp
+ Add to WatchlistBSX:US
9.1000 USD 0.0600 0.66%
Share
As of 20:04:05 ET on 05/17/2013.
More on BSX
News for Boston Scientific Corp (BSX)
-
COMPANY NEWS
-
PRESS RELEASES
-
INDUSTRY NEWS
- S&P 500 Stocks Biggest Weekly Changes in Target Price
- Boston Scientific’s Mahoney Says Watchman Key to Growth
- Nanostim’s Mini Wireless Pacemaker Shows Promise in Study
- St. Jude’s Durata Lead Shown to Be Safe in Analysis
- Littler, Edwards Wildman, MoFo, Venable: Business of Law
- U.S. Stock Options With Biggest Changes in Implied Volatility
- Largest NYSE Short Interest Changes as of April 15
- Coloplast Falls Amid Vaginal Mesh Lawsuits: Copenhagen Mover
- J&J, Samsung, General Motors: Intellectual Property
- J&J Wins Reversal of $482 Million Patent Verdict Over Stents
- U.S. Stock Options With Biggest Changes in Implied Volatility
- U.S. Stock Options With Biggest Changes in Implied Volatility
- Baucus Proves Democrat Foil Bowing to Montana on Revenues
- S&P 500 Short Interest Changes by Industry Group as of Feb. 28
- Boston Scientific’s Stroke Device Shows Mixed Results
- Boston Scientific Presents Clinical Data at Digestive Disease Week® Published 19 hours ago
- Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 Published May 17, 2013
- Vascular Solutions Files Patent Infringement Complaint Against Boston Scientific Published May 16, 2013
- Vital Therapies, Inc. Adds Two New Board Members Published May 16, 2013
- First Patient Enrolled In Boston Scientific Randomized Study Comparing WallFlex® Biliary RX Stent To Absence Of Biliary Published May 15, 2013
- OrbusNeich obtains additional preliminary injunction against Boston Scientific in Germany Published May 14, 2013
- Data From More Than 100,000 Boston Scientific Implantable Defibrillators Show Battery Longevity Projections Of Nine To 13 Years Published May 10, 2013
- Boston Scientific Receives CE Mark Approval For The Rhythmia™ Mapping System Published May 10, 2013
- MRI Interventions Announces First Quarter 2013 Financial Results Published May 09, 2013
- New Four-Year Data From Boston Scientific Demonstrated WATCHMAN® Device Was Superior To Warfarin For Mortality And Primary Published May 09, 2013
- Advanced Bionics Enters the World of Rehab Apps for Adults and Assessment Apps for Children Published May 08, 2013
- Boston Scientific To Participate In The Bank Of America Merrill Lynch 2013 Healthcare Conference Published May 08, 2013
- OrbusNeich enforces injunction against Boston Scientific in Germany Published May 07, 2013
- Local Business Enterasys Networks Joins Together To Help Stop Diabetes At The Annual North Shore Tour de Cure Published May 07, 2013
- There's More To Asthma Than Meets The Air Published May 07, 2013
- Primecap Rides Health to Top Growth Fund: Riskless Return
- Heart Patient Risk From iPad2 Found by 14-Year-Old
- Nanostim’s Mini Wireless Pacemaker Shows Promise in Study
- St. Jude’s Durata Lead Shown to Be Safe in Analysis
- Intuitive Trainer Denies Robot Surgery Training Was Watered Down
- Genetic Test Helps Identify Aggressive Prostate Cancer
- Intuitive Witnesses Blame Patient Death on Bad Heart
- Medtronic Wins Approval for Device to Resynchronize Heart
- The Future, Now: A Microchip You Wear on the Inside
- U.S. Stock Options With Biggest Changes in Implied Volatility
- Medtronic Deep Brain Stimulator Cited by FDA for Flaws
- Delcath Fails to Win U.S. Panel Backing for Cancer Device
- U.S. Stock Options With Biggest Changes in Implied Volatility
- Intuitive Salesman Says Robotic Surgeries Drove Salaries
- Cardiovascular Systems Confirms U.S. Information Request
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Advertisement
Rate this Page